The pipeline of biopharmaceutical drugs is rich and becoming increasingly diverse. Many new biologic modalities are being developed as established therapeutic classes move through their lifecycle. Wide arrays of different types of molecules are expected to coexist within product portfolios and manufacturing networks. It is clear that this will have a significant impact on manufacturing facilities. Strategies need to be developed to prepare facilities for these challenges.
The software tools provided by system and component suppliers can support them in this; they have been available for quite some time and their number is constantly growing. The short tips in this white paper are intended as a guide to selecting tools which will help you to save valuable time in the eight-phase model of the value creation process. This white paper offers guidance on the challenges in the individual value creation phases, support tools, how you can become even more productive with networked tools, and tips about which functions can be used and when.
Product life cycles are becoming ever shorter. Less and less time is available, whether for development of an installation or its possible modernization. Companies and their employees therefore try to continuously optimize their processes as that is the only way they can remain competitive and deal with increasingly demanding challenges. This white paper offers guidance on the challenges in the individual value creation phases, support tools, how you can become even more productive with networked tools, and tips about which functions can be used and when.
Laboratory automation equipment makers need to stay flexible in their outsourcing strategies because their make-versus-buy decision drivers can change over time — a good reason to conduct periodic reviews to validate the continued relevance of their outsourcing decisions.
Traditional Laboratory Information Management System (LIMS) implementations are notorious for keeping people awake at night. Industry analysts like Strategic Directions and ARC Advisory Group have estimated the failure rate of commercial LIMS solutions to be as high as 60 percent with many of them failing to deliver original customer requirements after lengthy and expensive deployments.
Electronic lab notebooks (ELNs) are one of the primary scientific informatics solutions for helping scientists design, execute, analyze and report on experiments—but selecting the right ELN can be a challenge.
Many leading life sciences companies have introduced cost-reduction initiatives to automate routine, non-value-added tasks related to data capture, cataloguing and documentation activities as products move from discovery through development to late-stage quality control, manufacturing and commercial operations.
When machine builders partner with subsystem specialists to simplify and streamline their equipment design, engineering, production, and support, they can save large amounts of time and, in many cases, up to 50 percent of costs — helping to boost profitability and customer satisfaction.
Guided Therapeutics, Inc., the maker of a rapid and painless testing platform based on its patented biophotonic technology, recently announced that it has sold the first LuViva Advanced Cervical Scan to its distributor in Russia